Last updated: 6 August 2019 at 11:45am EST

Dirk Kuyper Net Worth




The estimated Net Worth of Dirk Kuyper is at least $1.62 Million dollars as of 1 August 2019. Dirk Kuyper owns over 11,614 units of Conmed stock worth over $553,870 and over the last 17 years Dirk sold CNMD stock worth over $1,070,923.

Dirk Kuyper CNMD stock SEC Form 4 insiders trading

Dirk has made over 24 trades of the Conmed stock since 2007, according to the Form 4 filled with the SEC. Most recently Dirk exercised 11,614 units of CNMD stock worth $587,901 on 1 August 2019.

The largest trade Dirk's ever made was buying 690,000 units of Conmed stock on 2 July 2007 worth over $50,625,300. On average, Dirk trades about 20,088 units every 100 days since 2007. As of 1 August 2019 Dirk still owns at least 7,549 units of Conmed stock.

You can see the complete history of Dirk Kuyper stock trades at the bottom of the page.



What's Dirk Kuyper's mailing address?

Dirk's mailing address filed with the SEC is C/O CONMED CORPORATION, 525 FRENCH ROAD, UTICA, NY, 13502.

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti und Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.



What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500



Complete history of Dirk Kuyper stock trades at Alphatec Inc und Conmed

Insider
Trans.
Transaktion
Gesamtpreis
Dirk Kuyper
Direktor
Optionausübung $587,901
1 Aug 2019
Dirk Kuyper
Direktor
Verkauf $744,510
14 Jun 2019
Dirk Kuyper
Direktor
Optionausübung $131,102
31 May 2019
Dirk Kuyper
Direktor
Optionausübung $128,760
8 Apr 2019
Dirk Kuyper
Direktor
Optionausübung $149,588
1 Jun 2018
Dirk Kuyper
Direktor
Verkauf $52,240
13 Jun 2017
Dirk Kuyper
Direktor
Optionausübung $142,154
1 Jun 2017
Dirk Kuyper
Direktor
Optionausübung $123,180
1 Jun 2016
Dirk Kuyper
Direktor
Optionausübung $123,180
1 Jun 2016
Dirk Kuyper
Direktor
Optionausübung $167,100
1 Jun 2015
Dirk Kuyper
Direktor
Verkauf $42,850
1 Dec 2014
Dirk Kuyper
Direktor
Optionausübung $134,700
1 Jun 2014
Dirk Kuyper
Direktor
Kauf $31,630
15 Aug 2013
Dirk Kuyper
Präsident und CEO
Kauf $140,920
30 Aug 2011
Dirk Kuyper
Präsident und CEO
Kauf $49,680
12 Aug 2010
Dirk Kuyper
Präsident und CEO
Kauf $22,700
5 Jun 2008
Dirk Kuyper
Präsident und CEO
Verkauf $85,905
31 Mar 2008
Dirk Kuyper
Präsident und CEO
Verkauf $84,698
2 Jan 2008
Dirk Kuyper
Präsident und CEO
Kauf $4,520
27 Nov 2007
Dirk Kuyper
Präsident und CEO
Kauf $3,889
20 Nov 2007
Dirk Kuyper
Präsident und CEO
Verkauf $60,720
2 Oct 2007
Dirk Kuyper
Präsident und CEO
Kauf $34,500
28 Sep 2007
Dirk Kuyper
Präsident und CEO
Kauf $18,200
13 Sep 2007
Dirk Kuyper
Präsident und CEO
Kauf $2,566,800
2 Jul 2007


Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include: